Sinofn Health
Sinofn Health
Pioneering standard-setting metabolic nutrients and active cellular supplements customized for medical, clinical, and high-performance lifestyle applications.
How modern biochemistry and synthetic engineering are restructuring global medical foods, FSMPs, and cognitive wellness formulations.
In the contemporary wellness and medical industry, raw amino acid supply has evolved from basic dietary supplementation into target-specific therapeutic interventions. Today, clinical practitioners and nutritional developers are looking for products that boast absolute bio-availability, optimized molecular carriers, and strict adherence to hypoallergenic safety. The rise of Foods for Special Medical Purposes (FSMP) has highlighted a major industry demand for specialized, phenylalanine-free proteins and clinically standardized amino acids targeted toward specific inborn errors of metabolism, such as Phenylketonuria (PKU).
Additionally, the integration of synergistic compounds—such as Cyclic Adenosine Monophosphate (cAMP) extracted from plant sources like Jujube, and mitochondrial activators like Pyrroloquinoline Quinone (PQQ)—has redefined cognitive health, cell lifespan optimization, and energy transport systems. Global buyers are moving away from simple ingredient vendors and seeking scientific research-backed OEM/ODM development partners. By integrating molecular stability studies, simulated gastrointestinal digestion modeling, and precise particle size control (micro-encapsulation), leading factories like SINOFN are setting a new standard for functional nutrition output.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the prestigious Chinese Academy of Sciences (CAS).
Established in 2025, we operate from Shanghai as our global trading and strategic partnership hub. We provide international supplement brands, clinical diet distributors, and pharmaceutical innovators with premium, science-driven contract manufacturing services. Guided by deep bio-molecular insights, SINOFN translates academic research into highly specialized metabolic formulations and daily premium dietary supplements.
During her intensive clinical work, Mrs. GuoHong Liu witnessed the lifelong struggle of children diagnosed with Phenylketonuria (PKU). For these families, specialized metabolic foods were financially out of reach, forcing a compromise between neurological development and daily sustenance. Driven by clinical compassion to bridge this therapeutic gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods.
Her commitment attracted strategic investors and fueled transformative growth, establishing crucial pillars of the business:
"We measure success not just in revenue, but in lives improved through accessible science." – Mrs. GuoHong Liu, Founder
Building excellent product quality with a professional elite team. Our innovation pipeline translates advanced biochemical theories into active industrial products.
Through deep cooperation with top research universities and dedicated in-house research platforms, SINOFN has established a professional scientific research team. Led by postdoctoral researchers, metabolic medical doctors, and European dietary experts, we continuously explore cutting-edge technologies and product innovations.
Associate Researcher and Postdoctoral Fellow at the Chinese Academy of Sciences (CAS). Specialist in bioactive compound delivery systems, micro-encapsulation, and targeted amino acid absorption kinetics.
Ph.D. from Peking University Medical School. Brings over 15 years of clinical and academic experience in metabolic disorder formulations, specialized dietary interventions, and pediatric amino acid therapies.
Senior Scientist from the Netherlands serving as Chief Engineer. Specially appointed EU regulatory specialist in nutraceutical delivery technology, stabilizing specialized medical foods for the Western market.
Unlocking the supply chain advantages, speed, and precision of China's advanced manufacturing.
By situating our logistics hubs in Shanghai and our research-production assets across advanced industrial hubs in China, SINOFN leverages unparalleled manufacturing efficiencies. Our production facilities maintain raw material sourcing networks, high-output automation, and sophisticated internal batch-tracking protocols. This enables us to provide cost structures and rapid market turnaround times that European or North American facilities cannot match.
Our Tianjin and regional plants prioritize vertical integration. This ensures that custom synthesized amino acids, plant-based polysaccharides, and active co-enzymes move directly from bio-fermentation tanks to advanced packaging tables under strict sterile control, minimizing oxygen degradation and microbial risk.
Over 10 dedicated manufacturing lines supporting softgels, gummies, liquids, and powder encapsulation.
Certifications: ISO 22000, HACCP, FSSC 22000 certified.
Annual Capacity: 500M+ units.
Fully equipped analytics lab including HPLC and GC-MS instrumentation for contaminant screening.
Procedures: Strict microbiological safety testing, heavy metal scans, stability and dissolution validations.
Pilot-scale prototyping setups for tablets, hard capsules, and specialized oral liquids.
Focus: Bioavailability optimization studies, real-time stability chambers, and advanced organoleptic optimization.
Seamless material transition logic: Raw Material Storage → Production → Unit Packaging.
Security: Blockchain-based batch tracking, BRCGS-certified warehousing and climate-controlled depots.
Ensuring seamless custom clearances, compliance validations, and logistical assurance across continents.
Enterprise procurement departments face complex regulatory pathways when importing amino acid formulations and infant metabolic products. In the North American market, FDA compliance, non-GMO verifications, and GRAS (Generally Recognized as Safe) certifications are mandatory prerequisites. In the EU, EFSA regulations demand strict clinical proof of ingredient safety and allergen-free profiles, particularly under the classification of FSMP (Foods for Special Medical Purposes).
SINOFN streamlines this process through extensive documentation. We provide complete dossiers including stability profiles, molecular assay metrics, and pesticide residue analytics. Our production capabilities align with the demands of several localized application scenarios:
Sinofn prioritizes intellectual property and strict quality compliance, holding 36 patents (including 11 invention patents, 12 utility model patents, 11 software copyrights, and 2 design patents) and 71 multi-category registered trademarks. We are certified with ISO9001, ISO22000, HACCP, and HALAL, demonstrating our commitment to quality and safety.
From specialized metabolic formulas to advanced daily functional delivery formats, discover our full spectrum of contract manufacturing capabilities.
